TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Urogyn Sverige AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/08 |
| Turnover |
4,331
|
5,204
|
4,170 |
| Financial expenses |
699
|
63
|
19 |
| Earnings before taxes |
-8,817
|
-501
|
4,944 |
| EBITDA |
-45,270
|
-41,260
|
-19,917 |
| Total assets |
23,954
|
21,337
|
17,873 |
| Current assets |
5,729
|
6,451
|
10,525 |
| Current liabilities |
7,943
|
7,390
|
2,831 |
| Equity capital |
1,724
|
9,198
|
13,639 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
6
|
23
|
14 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/08 |
| Solvency |
7.2%
|
43.1%
|
76.3% |
| Turnover per employee |
722
|
226
|
298 |
| Profit as a percentage of turnover |
-203.6%
|
-9.6%
|
118.6% |
| Return on assets (ROA) |
-33.9%
|
-2.1%
|
27.8% |
| Current ratio |
72.1%
|
87.3%
|
371.8% |
| Return on equity (ROE) |
-511.4%
|
-5.4%
|
36.2% |
| Change turnover |
-873
|
1,034
|
809 |
| Change turnover % |
-17%
|
25%
|
24% |
| Chg. No. of employees |
-17
|
9
|
1 |
| Chg. No. of employees % |
-74%
|
64%
|
8% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.